Filter
130
Filtered Results: 130
Text search:
National
Centre
for
Disease
Control
(formerly
National
Institute
of
Communicable
Diseases)
Featured
Recommendations
10
New Publications
44
Language
Document type
No document type
88
Studies & Reports
18
Guidelines
11
Manuals
9
Strategic & Response Plan
3
Training Material
1
Countries / Regions
India
11
Western and Central Europe
9
Nepal
5
South Africa
5
Bangladesh
4
Ukraine
3
Myanmar / Burma
3
Eastern Europe
3
Global
3
Philippines
2
Syria
2
Kenya
2
Tanzania
2
Rwanda
2
Sierra Leone
1
Ethiopia
1
Ghana
1
Uganda
1
Jordan
1
Germany
1
Thailand
1
Mozambique
1
Namibia
1
East and Southern Africa
1
South–East Asia Region
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Asia
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
42
Clinical Guidelines
15
Public Health
14
Key Resources
10
Women & Child Health
7
Capacity Building
2
Toolboxes
Rapid Response
10
Disability
9
Mental Health
9
TB
9
NTDs
8
Ebola
6
HIV
6
Refugee
5
COVID-19
4
Planetary Health
4
Natural Hazards
3
Global Health Education
3
AMR
3
Conflict
2
Pharmacy
2
Cholera
1
Caregiver
1
NCDs
1
The purpose of this document is to provide interim guidance for setting up of quarantine facilities
Accessed: 16.04.2020
Draft version 2017
Prevention and Control of Cholera Uganda
recommended
Operational Guidelines for the national and district health workers & planners.
These new approaches include use of selective chemotherapy, Rapi...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute R...
National Tuberculosis Control Program; Mycobacterial Disease Control ... AIDS/STD Program
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Afric...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual ev...
An Update will be published in late 2018
Despite the significant role of vector control in national leishmaniasis control programmes, the...
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test ... rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other national health guidelines. It is intended to serve as the main guiding document for national, regional and local programme managers, clinicians, coordinators, laboratory staff and other health workers; national and regional reference laboratories; local and international implementing partners; and donors involved in TB control.
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust ...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of ... spread, severe illness and death.1 AMR in recent years has become
a global priority in public health due to its widespread consequences and increasing occurrence from
time to time. AMR has a formidable impact where the existing antibiotics and other antimicrobial
medicines become ineffective, and infections become increasingly difficult or impossible to treat.
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non ... Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of use to pathologists, cytometrists, hematologists, technologists and scientists working in this field.
